Treatment of Vasomotor Rhinitis in Pregnancy
Vasomotor rhinitis presenting during pregnancy requires a careful clinical approach: achieving symptom control while accounting for fetal safety. Intranasal saline instillation is a well-recognised first measure in this population, and vasomotor rhinitis in pregnancy is known to respond well to it.
This protocol is specific to patients with vasomotor rhinitis in the context of pregnancy. The gravid state is the defining condition shaping every management decision — non-pharmacological and pharmacological alike.
When symptoms persist, certain FDA-approved intranasal agents may be considered — selection depends on pregnancy safety categorisation and a careful weighing of individual risks against benefits. Non-pharmacological measures may also contribute to symptom reduction. The complete selection framework, sequencing, and agent-specific guidance are available in the structured protocol below.
Vasomotor rhinitis in pregnancy responds well to intranasal saline instillation.
Potential risks versus benefits should be considered in the use of FDA-approved topical anticholinergics (pregnancy category B), topical antihistamines (pregnancy category C), and topical corticosteroids (pregnancy category C).
Exercise appropriate for physical condition and gestational age also may reduce symptoms.
View source ↗